127 related articles for article (PubMed ID: 34415221)
1. Thermal shift assays of marine-derived fungal metabolites from
Cardona HRA; Froes TQ; Souza BC; Leite FHA; Brandão HN; Buaruang J; Kijjoa A; Alves CQ
J Biomol Struct Dyn; 2022; 40(22):11968-11976. PubMed ID: 34415221
[TBL] [Abstract][Full Text] [Related]
2. Hydroxytakakiamide and Other Constituents from a Marine Sponge-Associated Fungus
Arias Cardona HR; Cerqueira da Silva B; de Lima FO; Andrade Leite FH; de Souza BC; Brandão HN; David JM; Alves CQ; Kijjoa A
Mar Drugs; 2024 Feb; 22(3):. PubMed ID: 38535438
[TBL] [Abstract][Full Text] [Related]
3. Computational studies on potential small molecule inhibitors of
Boakye A; Gasu EN; Mensah JO; Borquaye LS
J Biomol Struct Dyn; 2023; 41(21):12128-12141. PubMed ID: 36632757
[TBL] [Abstract][Full Text] [Related]
4. Antileishmanial activity evaluation of thiazolidine-2,4-dione against Leishmania infantum and Leishmania braziliensis.
Neri FSM; Júnior DBC; Froes TQ; da Silva PBG; do Egito MS; Moreira POL; de Pilla Varotti F; Castilho MS; Teixeira-Neto RG; de Albuquerque JFC; Leite FHA
Parasitol Res; 2020 Jul; 119(7):2263-2274. PubMed ID: 32462293
[TBL] [Abstract][Full Text] [Related]
5. The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major.
Nare B; Hardy LW; Beverley SM
J Biol Chem; 1997 May; 272(21):13883-91. PubMed ID: 9153248
[TBL] [Abstract][Full Text] [Related]
6. Thiadiazine-thiones as inhibitors of leishmania pteridine reductase (PTR1) target: investigations and in silico approach.
Shtaiwi A
J Biomol Struct Dyn; 2023 Aug; ():1-10. PubMed ID: 37578348
[TBL] [Abstract][Full Text] [Related]
7. In Silico Identification and In Vitro Evaluation of Natural Inhibitors of Leishmania major Pteridine Reductase I.
Herrmann FC; Sivakumar N; Jose J; Costi MP; Pozzi C; Schmidt TJ
Molecules; 2017 Dec; 22(12):. PubMed ID: 29211037
[TBL] [Abstract][Full Text] [Related]
8. PTR1: a reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major.
Bello AR; Nare B; Freedman D; Hardy L; Beverley SM
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11442-6. PubMed ID: 7972081
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning, expression and enzymatic assay of pteridine reductase 1 from Iranian lizard Leishmania.
Kazemi B; Tohidi F; Bandehpour M; Yarian F
Iran Biomed J; 2010 Jul; 14(3):97-102. PubMed ID: 21079660
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.
Hardy LW; Matthews W; Nare B; Beverley SM
Exp Parasitol; 1997 Nov; 87(3):157-69. PubMed ID: 9371081
[TBL] [Abstract][Full Text] [Related]
11. New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity.
Nare B; Luba J; Hardy LW; Beverley S
Parasitology; 1997; 114 Suppl():S101-10. PubMed ID: 9309772
[TBL] [Abstract][Full Text] [Related]
12. An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors.
Leite FHA; Froes TQ; da Silva SG; de Souza EIM; Vital-Fujii DG; Trossini GHG; Pita SSDR; Castilho MS
Eur J Med Chem; 2017 May; 132():322-332. PubMed ID: 28407565
[TBL] [Abstract][Full Text] [Related]
13. Structure-guided discovery of thiazolidine-2,4-dione derivatives as a novel class of Leishmania major pteridine reductase 1 inhibitors.
Leite FHA; Santiago PBGDS; Froes TQ; da Silva Filho J; da Silva SG; Ximenes RM; de Faria AR; Brondani DJ; de Albuquerque JFC; Castilho MS
Eur J Med Chem; 2016 Nov; 123():639-648. PubMed ID: 27517809
[TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani pteridine reductase 1: biochemical properties and structure-modeling studies.
Kumar P; Kumar A; Verma SS; Dwivedi N; Singh N; Siddiqi MI; Tripathi RP; Dube A; Singh N
Exp Parasitol; 2008 Sep; 120(1):73-9. PubMed ID: 18617167
[TBL] [Abstract][Full Text] [Related]
15. Structure of pteridine reductase (PTR1) from Leishmania tarentolae.
Zhao H; Bray T; Ouellette M; Zhao M; Ferre RA; Matthews D; Whiteley JM; Varughese KI
Acta Crystallogr D Biol Crystallogr; 2003 Sep; 59(Pt 9):1539-44. PubMed ID: 12925782
[TBL] [Abstract][Full Text] [Related]
16. A pteridine reductase gene ptr1 contiguous to a P-glycoprotein confers resistance to antifolates in Trypanosoma cruzi.
Robello C; Navarro P; Castanys S; Gamarro F
Mol Biochem Parasitol; 1997 Dec; 90(2):525-35. PubMed ID: 9476799
[TBL] [Abstract][Full Text] [Related]
17. Identification of Kaurane-Type Diterpenes as Inhibitors of Leishmania Pteridine Reductase I.
Herrera-Acevedo C; Flores-Gaspar A; Scotti L; Mendonça-Junior FJB; Scotti MT; Coy-Barrera E
Molecules; 2021 May; 26(11):. PubMed ID: 34063939
[TBL] [Abstract][Full Text] [Related]
18. Leishmania donovani pteridine reductase 1: comparative protein modeling and protein-ligand interaction studies of the leishmanicidal constituents isolated from the fruits of Piper longum.
Sahi S; Tewatia P; Ghosal S
J Mol Model; 2012 Dec; 18(12):5065-73. PubMed ID: 22752544
[TBL] [Abstract][Full Text] [Related]
19. Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development.
Cavazzuti A; Paglietti G; Hunter WN; Gamarro F; Piras S; Loriga M; Allecca S; Corona P; McLuskey K; Tulloch L; Gibellini F; Ferrari S; Costi MP
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1448-53. PubMed ID: 18245389
[TBL] [Abstract][Full Text] [Related]
20. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani.
Kaur J; Sundar S; Singh N
J Antimicrob Chemother; 2010 Aug; 65(8):1742-8. PubMed ID: 20519355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
